Cyclin-dependent kinase substrate

Cyclin-dependent kinase (CDK) substrates are a diverse group of proteins that undergo phosphorylation by CDK-cyclin complexes to drive essential cellular transitions, primarily within the cell cycle. The most prominent example is the Retinoblastoma protein (pRb), which, when phosphorylated by CDK4/6 and CDK2, releases E2F transcription factors to initiate the G1-to-S phase transition. Other critical substrates include p27, p53, RNA polymerase II, and various cytoskeletal proteins that coordinate mitosis and transcriptional elongation. In drug development, these substrates are generally not the direct targets of small molecules or antibodies; instead, the kinases that modify them (such as CDK4 and CDK6) are the primary therapeutic targets. Consequently, the phosphorylation status of these substrates often serves as a key pharmacodynamic biomarker for monitoring the efficacy of CDK inhibitors in oncology. Dysregulation of the CDK-substrate axis is a hallmark of many cancers, where overactive kinases lead to aberrant substrate modification and uncontrolled cell proliferation.

Other names

CDK substratesCyclin-dependent kinase targetsPhosphorylation targets of CDKsCDK downstream effectors

Inhibition of cyclin-dependent kinases (CDKs) prevents the phosphorylation and subsequent activation or inactivation of these substrates, leading to cell cycle arrest at specific checkpoints.